Roundview Capital LLC Has $8.48 Million Stock Holdings in Danaher Co. (NYSE:DHR)

Roundview Capital LLC raised its stake in Danaher Co. (NYSE:DHR) by 2.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 36,953 shares of the conglomerate’s stock after purchasing an additional 958 shares during the period. Roundview Capital LLC’s holdings in Danaher were worth $8,483,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Howard Capital Management Group LLC boosted its holdings in shares of Danaher by 4.1% during the third quarter. Howard Capital Management Group LLC now owns 1,229 shares of the conglomerate’s stock worth $342,000 after acquiring an additional 48 shares during the period. CreativeOne Wealth LLC boosted its stake in Danaher by 24.7% in the 3rd quarter. CreativeOne Wealth LLC now owns 1,542 shares of the conglomerate’s stock valued at $429,000 after purchasing an additional 305 shares during the period. Edgestream Partners L.P. grew its holdings in Danaher by 466.1% in the 3rd quarter. Edgestream Partners L.P. now owns 10,965 shares of the conglomerate’s stock valued at $3,048,000 after buying an additional 9,028 shares in the last quarter. Erste Asset Management GmbH bought a new position in Danaher during the 3rd quarter worth $5,988,000. Finally, FSA Wealth Management LLC acquired a new stake in shares of Danaher during the third quarter worth $50,000. 79.05% of the stock is owned by institutional investors.

Analysts Set New Price Targets

DHR has been the topic of several research reports. Robert W. Baird decreased their price target on shares of Danaher from $277.00 to $268.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $277.00 target price (down from $299.00) on shares of Danaher in a report on Thursday, January 30th. Wells Fargo & Company cut their price target on Danaher from $280.00 to $240.00 and set an “equal weight” rating for the company in a research note on Thursday, January 30th. Citigroup lowered their price objective on Danaher from $285.00 to $265.00 and set a “buy” rating on the stock in a research note on Thursday, January 30th. Finally, Raymond James reiterated a “market perform” rating on shares of Danaher in a research report on Monday, February 3rd. Five analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $278.24.

Danaher Stock Performance

NYSE DHR opened at $205.01 on Tuesday. The firm’s fifty day moving average price is $213.91 and its two-hundred day moving average price is $235.91. The stock has a market cap of $146.52 billion, a PE ratio of 38.83, a PEG ratio of 2.66 and a beta of 0.82. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. Danaher Co. has a fifty-two week low of $196.80 and a fifty-two week high of $281.70.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter last year, the company posted $2.09 EPS. On average, equities analysts expect that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be given a dividend of $0.32 per share. The ex-dividend date of this dividend is Friday, March 28th. This is an increase from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 annualized dividend and a yield of 0.62%. Danaher’s dividend payout ratio (DPR) is currently 24.24%.

Insiders Place Their Bets

In other news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the transaction, the senior vice president now owns 20,230 shares in the company, valued at approximately $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 11.10% of the company’s stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.